EN | ES
Salvat
  • Salvat
  • Activities
  • Partnering & Services
  • Products
  • Commitment
  • Careers
  • Media
  • Connect
  • Menu

Salvat’s News and Press kit

Media

Salvat at a glance

Press Kit

What are we doing right now

News

Media

Press Kit

Salvat at a glance

If you are a media professional and wish to receive more information, please send us an email at media@svt.com.

YOU CAN DOWNLOAD OUR PRESS KIT HERE:

SALVAT PRESS KIT

English Version PDF

Download

News

What are we doing right now

Patronage of Laboratorios Salvat at the Choir of the Faculty of Pharmacy

21/12/2017/in Salvat Foundation /by adminsvt

The new agreement between the University of Barcelona and Salvat Laboratories has been signed so that they once again commit themselves to lend a hand in the form of patronage at the Choir of the Faculty of Pharmacy. Directed by Ahmet Süleyman Bilgin, with more than thirty vocalists, the choir has a wide musical repertoire, with […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 adminsvt https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png adminsvt2017-12-21 06:10:152018-07-12 11:51:59Patronage of Laboratorios Salvat at the Choir of the Faculty of Pharmacy

Pediapharm Announces the Commercial Launch of Otixal™ in Canada

18/05/2017/in Salvat International /by adminsvt

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Pediapharm Inc. (“Pediapharm” or the “Company”) (TSX VENTURE:PDP) is pleased to announce today the Canadian commercial launch of Otixal™ (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution for the treatment of acute otitis media with tympanostomy tubes (“AOMT”) in […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 adminsvt https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png adminsvt2017-05-18 06:01:582018-01-25 09:51:15Pediapharm Announces the Commercial Launch of Otixal™ in Canada

Salvat launches Ekzem

15/01/2017/in Salvat Spain /by adminsvt

We present Ekzem®, the first and only medicinal product indicated for the treatment of eczematous otitis externa Up until the recent release of Ekzem®, launched by SALVAT this January 2017, there was no medicinal product in Spain specifically indicated for the treatment of eczematous otitis externa. Up until now, otorhinolaryngologists, primary care physicians and other […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 adminsvt https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png adminsvt2017-01-15 05:39:052018-01-25 09:53:47Salvat launches Ekzem

Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC Announce the Launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution

29/08/2016/in Salvat USA /by adminsvt

BARCELONA, Spain and ATLANTA, Aug. 29, 2016 /PRNewswire/ — Laboratorios SALVAT S.A. (SALVAT) and Arbor Pharmaceuticals, LLC (Arbor) jointly announce the launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution, the first and only antibiotic and steroid combination ear drop available in sterile, preservative-free single-dose vials. OTOVEL® is owned by SALVAT, […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 adminsvt https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png adminsvt2016-08-29 05:56:052018-01-25 09:55:39Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC Announce the Launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution
Page 5 of 512345

CATEGORIES

  • Salvat Foundation
  • Salvat International
  • Salvat Spain
  • Salvat USA

LATEST NEWS

  • Salvat plans to launch the first global ocular corticosteroid with nanoemulsion in 2023 for the inflammation and pain after ocular surgery21/04/2022 - 2:46 pm

    Phase III clinical trials conducted in US confirm that clobetasol is effective and safe in the treatment of inflammation and pain after cataract surgery. The pharmaceutical company has begun the process with health authorities to market the new corticosteroid worldwide by the middle of next year. The company has patented a pioneering technology, IMPACT-SVT®, which […]

  • Salvat Laboratories enters in the Hong Kong market with its first otic medication14/10/2021 - 1:30 pm

    Salvat has an agreement with Lee’s Pharmaceutical to distribute the otic treatment Cetraxal Plus in China, Hong Kong and Taiwan. The product has been available in the Spanish market for twenty years and is exported to more than 50 countries. Cetraxal Plus is the only otic treatment in the world that comes in single-dose vials […]

  • Salvat completes Phase III clinical trials of its new ophthalmic corticosteroid nanoemulsion03/06/2021 - 3:06 pm

    The aim of these trials, which began in 2020, is to prove the efficacy of this innovative drug in treating ocular inflammation and pain after cataract surgery. For the first time in the world, this new product will use nanoparticles applied to the eye in order to help the drug’s absorption and application. With an […]

  • Salvat
  • Mission, Vision & Values
  • The Company
  • Our History
  • Salvat USA
  • Salvat Worldwide
  • Our People
  • Activities
  • R+D
  • Product Pipeline
  • Partnering
  • Manufacturing
  • Pharmaloop
  • Sales
  • Partnering & Services
  • Licensing and Partnership
  • CDMO Services
  • Innovation and Technology
  • Meet Us
  • Products
  • Otolaryngology
  • Ophthalmology
  • Gastroenterology
  • Other Therapeutic Areas
  • Consumer Healthcare
  • Full Product List
  • Commitment
  • Corporate Citizenship
  • Transparency
  • Memberships
  • Salvat Foundation
  • Careers
  • Working at Salvat
  • Send your CV
  • Media
  • Press Kit
  • News
  • Connect
  • Contact Us
  • Salvat Replies
  • Disclaimer
  • Cookies
  • © Salvat 2020, All Rights Reserved
  • Twitter
  • Linkedin
  • Facebook

Usamos 'cookies' para personalizar el contenido y analizar el uso de nuestro sitio web. Si hace clic en "Aceptar", da su consentimiento para el uso de éstas y navegará directamente a la página web. Si no quiere aceptar algunas de las ‘cookies’ o quiere saber más acerca de cómo usamos las ‘cookies’, haga click en “Personalizar”.

VER POLÍTICA DE  COOKIES


We use 'cookies' to personalize content and analyze the use of our website. By clicking "I Accept", you consent to their use and will navigate directly to the website. If you do not want to accept some of the ‘cookies’ or want to know more about how we use the ‘cookies, click on“ Personalize”.

VIEW COOKIES POLICY

ACEPTAR / I ACCEPTPERSONALIZAR / PERSONALIZE
Manage consent

Personalizar / Personalize

Aquí puede elegir las cookies que se guardan en su navegador:
Here you can select the cookies allowed to be stored on your browser:
Analytics
These cookies collect information about how visitors make use of the website, such as page views, loading errors… It is generic and anonymous information where personal data are not included nor collects information that identifies visitors; with the ultimate aim to improve the functioning of the website.

CookieDurationDescription
_ga2 yearsGoogle Analytics
_gat_gtag_UA_112188601_12 yearsGoogle Analytics
_gid2 yearsGoogle Analytics
Necessary
Always Enabled
These cookies are necessary for the proper use of the website, allowing access to sections that have security filters. Without these cookies, many of the features would not be operating.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
ip2location_redirection_first_visitsessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
PHPSESSIDsessionIdentificador de sesión PHP / PHP session id
prescriptionModalAcceptedsessionIdentificador de sesión PHP / PHP session id
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
wpml_browser_redirect_testsessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
_icl_visitor_lang_jssessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
SAVE & ACCEPT
  Scroll to top